Unidad de Cirugía Bariátrica, Hospital Universitario de Bellvitge - IDIBELL, Hospitalet de Llobregat, Barcelona, Spain.
Unidad de Cirugía Bariátrica, Hospital Universitario de Bellvitge - IDIBELL, Hospitalet de Llobregat, Barcelona, Spain.
Cir Esp (Engl Ed). 2021 Aug-Sep;99(7):514-520. doi: 10.1016/j.cireng.2021.06.017. Epub 2021 Jul 1.
The "Single Anastomosis Duodeno-Ileal bypass with Sleeve gastrectomy" (SADI-S) is a bariatric surgery conceived to simplify the duodenal switch in order to reduce its postoperative complications. The objective of this study is to assess the safety and efficacy of SADI-S, comparing its results in both direct and two-step procedure.
Unicentric cohort study that includes patients submitted to SADI-S, both direct or in two-step, between 2014 and 2019.
Two hundred thirty-two patients were included, 192 were submitted to direct SADI-S and 40 had previously undergone a sleeve gastrectomy. The severe complications rate (Clavien-Dindo ≥ IIIA) was 7.8%, being hemoperitoneum and duodenal stump leak the most frequent ones. One patient was exitus between the first 90 days after surgery (0.4%). Patients submitted to direct SADI-S had an initial body mass index (BMI) of 49.6 kg/m in comparison of 56.2 kg/m in the two-step SADI-S (P < .001). The mean excess weight loss (EWL) at two years was higher in direct SADI-S (77.3 vs. 59.3%, P < .05). Rate of comorbidities resolution was 88.5% for diabetes, 73.0% for hypertension, 77.0% for dyslipidemia and 85.7% for sleep apnea, with no differences between both techniques.
In medium term, SADI-S is a safe and effective technique that offers a satisfactory weight loss and remission of comorbidities. Patients submitted to two-step SADI-S had a higher initial BMI and presented a lower EWL than direct SADI-S.
“单吻合口十二指肠空肠旁路与袖状胃切除术”(SADI-S)是一种减重手术,旨在简化十二指肠转流术,以减少其术后并发症。本研究旨在评估 SADI-S 的安全性和有效性,并比较直接手术和两步手术的结果。
这是一项单中心队列研究,纳入了 2014 年至 2019 年间接受 SADI-S 手术的患者,包括直接手术和两步手术。
共纳入 232 例患者,其中 192 例行直接 SADI-S,40 例患者此前行袖状胃切除术。严重并发症发生率(Clavien-Dindo≥IIIa)为 7.8%,最常见的是腹腔积血和十二指肠残端漏。1 例患者在术后 90 天内死亡(0.4%)。直接 SADI-S 组患者的初始体重指数(BMI)为 49.6kg/m,而两步 SADI-S 组为 56.2kg/m(P<0.001)。直接 SADI-S 组的两年内平均体重减轻率(EWL)更高(77.3%比 59.3%,P<0.05)。糖尿病的缓解率为 88.5%,高血压为 73.0%,血脂异常为 77.0%,睡眠呼吸暂停为 85.7%,两种技术之间无差异。
在中期,SADI-S 是一种安全有效的技术,可提供令人满意的体重减轻和并发症缓解。两步 SADI-S 组患者的初始 BMI 更高,而直接 SADI-S 组的 EWL 较低。